Skip to content
Sectors How it works Pricing Client stories

Insights

Companies Live signals Events Markets Trends Company lists
Client Area Book a 7-day Readout
Tsingke Biotech logo — Leading DNA/RNA synthesis innovator, delivering advanced syn...

Tsingke Biotech

Leading DNA/RNA synthesis innovator, delivering advanced synthetic genomics products for groundbreaking genetic research

Founded 2004 China Beijing, China 13 employees Series B Total: $600.00M Biotechnology, Health Care

General Information

Company Name Tsingke Biotech
Founded Year 2004
Location China Beijing, China
Employees 13
Industries Biotechnology, Health Care
Funding Stage Series B
Social

BounceWatch is an independent company data service, not affiliated with Tsingke Biotech. To contact Tsingke Biotech, visit tsingke.com.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

How does Tsingke Biotech compare?

A PDF of Tsingke Biotech and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.

See a sample report

This takes a few seconds: we look beyond our own index too.

Meeting Tsingke Biotech soon?

A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample

About Tsingke Biotech

Tsingke Biotech is a leading innovator in DNA/RNA synthesis, providing advanced synthetic genomics products for pioneering genetic research. Founded in 2017 and headquartered in China, Tsingke Biotech is positioned as an independent gene synthesis platform company with a comprehensive industry chain. The company's diverse business scope encompasses synthetic genomics products and services, life science research equipment and raw materials, and Bio-manufacturing CXO. The company's distinctive proposition lies in its development of the "Gene Factory", establishing a synthesis platform comprising a production facility for raw materials and equipment in gene synthesis elements, a gene intelligent molecule splitting and assembly technology platform, and an intelligent AI algorithm platform propeller system (TSINGKE HELIXTECH). This infrastructure enables Tsingke to offer customers a range of services including gene synthesis, antibody proteins, gene regulation, testing, reagents, instruments, and technical services. With a mission focused on "Biotech for a better world" and guided by the values of "Quality, Innovation, Striving, and Win-win", Tsingke Biotech has garnered significant attention in the biotechnology and healthcare industries. The company recently secured a CNY400.00M Series B investment on 05 December 2022, with participation from notable investors including Qingsong Fund, Fortune Venture Capital, Capitallink, Jolmo Capital, Zhongyuan Asset Management, and Henan CICC Huirong Fund Management. Tsingke Biotech's commitment to pioneering innovations in biomanufacturing positions it as a key player in shaping the future of the industry. Its focus on industry needs and dedication to continuous improvement make it an intriguing prospect for investors and a driving force in advancing genetic research and biotechnology. Follow their LinkedIn page for the latest updates and insights on this captivating journey of innovation and discovery.

Business keywords: DNA Synthesis, RNA Synthesis, Gene Synthesis, Synthetic Genomics, Molecular Biology, Genetic Research, Bio-Manufacturing, Synthetic Biology, Oligo Synthesis, Gene Regulation, Antibody Proteins, Life Science Research, Biomanufacturing CRO/CDMO, Artificial Intelligence in Biotech

Funding Rounds & Investors (2)

View All
Funding Stage Amount Investors Lead Investors Date
Series B CNY400.00M 7
Qingsong Fund Fortune Venture Capital 江苏金茂创业投资管理有限公司
Qingsong Fund, Fortune Venture Capital +5
05 Dec 2022
Series A CNY200.00M 3
SBCVC Yueyin Venture Capital 上海盛宇股权投资基金管理有限公司
SBCVC, Yueyin Venture Capital +1
01 Jan 2022

Tsingke Biotech Alternatives & Competitors

View All Alternatives
Tsingke Biotech vs
Camena Bioscience
Camena Bioscience United Kingdom

Unlocking access to genes with unparalleled accuracy

Series A
23 employees
Biotechnology, Health Care
Tsingke Biotech vs
DNA Script
DNA Script France

Transforming how molecular biology translates to human health, personalized medicine and synthetic b...

Series C
132 employees
Biotechnology, Health Care
Tsingke Biotech vs
Integrated DNA Technologies
Integrated DNA Technologies United States

Lab to life-changing advances. We’ll help.

Acquired
1771 employees
Biotechnology, Health Care
Compare Tsingke Biotech vs Integrated DNA Technologies
View all alternatives

FAQ About Tsingke Biotech

Leading DNA/RNA synthesis innovator, delivering advanced synthetic genomics products for groundbreaking genetic research
Tsingke Biotech was founded in 2004.
Tsingke Biotech is headquartered in Beijing, China.
Tsingke Biotech operates in Biotechnology and Health Care. Its work centres on DNA Synthesis, RNA Synthesis, Gene Synthesis and Synthetic Genomics.
Tsingke Biotech has approximately 13 employees.
Tsingke Biotech has completed 2 funding rounds, raising a total of $600.00M. The latest funding stage is Series B.
Top alternatives and competitors to Tsingke Biotech include Camena Bioscience, DNA Script, Integrated DNA Technologies, Synbio Technologies, GeneX India Bioscience Pvt Ltd. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Tsingke Biotech and Camena Bioscience are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for Tsingke Biotech, https://bouncewatch.com/company/tsingke-biotech, updated 14 January 2025. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Talk to an analyst Book a 7-day Readout